An atypical nevus (also called a dysplastic nevus) is a mole that looks noticeably different from ordinary moles. It tends to be larger than a pencil eraser, has irregular or blurry borders, and contains a mix of colors rather than a single uniform shade. While atypical nevi are not cancerous, they signal a higher baseline risk for melanoma, especially when a person has many of them or a family history of skin cancer.
How Atypical Nevi Look Different
Most common moles are small, round, evenly colored, and have clean edges. An atypical nevus breaks one or more of those rules. It may have some or all of these features:
- Shape: Irregular or asymmetrical rather than round or oval
- Borders: Ragged, blurry, or fading into the surrounding skin instead of having a crisp edge
- Color: A mix of pink, red, tan, brown, or black within the same mole
- Size: Larger than 6 millimeters (roughly the width of a pencil eraser), though some are smaller
- Surface: Flat with a slightly pebbly or raised center, while the edges stay flat
These features overlap with the “ABCDE” criteria used to spot early melanoma (asymmetry, border irregularity, color variation, diameter, evolution). That overlap is exactly why atypical nevi get attention: they can be difficult to distinguish from melanoma by appearance alone, and sometimes a biopsy is the only way to tell.
What Happens Under the Microscope
When a dermatologist biopsies a suspicious mole, a pathologist examines the tissue for two things: how the pigment-producing cells (melanocytes) are organized, and how abnormal those individual cells look. In an atypical nevus, the melanocytes form irregular clusters instead of neat, orderly nests, and they may spread upward into layers of skin where they don’t normally appear. The cells themselves can vary in size and shape, with darker, clumpier DNA inside their nuclei.
Pathologists have traditionally graded atypia on a three-tier scale: mild, moderate, and severe. Many labs are now shifting to a simpler two-tier system. In the newer system, moles that used to be called “mildly atypical” are reclassified as having minimal cytological atypia, essentially just slightly unusual-looking cells. What was previously called moderate dysplasia becomes “low-grade,” and what was called severe becomes “high-grade,” based on whether the abnormal cell nuclei are larger or smaller than 1.5 times the size of the surrounding skin cells. The grade matters because it directly affects what your dermatologist recommends next.
How Atypia Grade Shapes Treatment
The American Academy of Dermatology has reached consensus that mildly atypical nevi should not be surgically removed after biopsy. The transformation rate from a mildly dysplastic nevus to melanoma is estimated at roughly 1 in 10,000, which is extremely low. For these moles, clinical monitoring (regular skin checks) replaces surgery as the standard approach.
For moderate or high-grade atypia, management becomes more individualized. Many dermatologists recommend complete removal of moderately or severely atypical nevi, particularly if the biopsy didn’t capture the full lesion. Your dermatologist will factor in the grade, your personal history, and whether the mole was fully removed during biopsy when making that call. If a re-excision is recommended, the procedure is straightforward: a small area of normal-looking skin around the biopsy site is removed under local anesthesia to ensure no abnormal cells remain at the margins.
The Link to Melanoma Risk
Having atypical nevi doesn’t mean you have or will develop melanoma. It does mean your overall risk is elevated compared to someone without them. The risk increases with the number of atypical moles. Research has found that people under 60 with more than five atypical nevi had roughly 2.4 times the odds of developing thicker (more advanced) melanoma compared to those with no atypical moles.
Interestingly, the relationship between mole count and melanoma is not as straightforward as it might seem. Having a high total number of ordinary moles (more than 50) was actually associated with a lower risk of thick melanoma in the same study. This may reflect the fact that people with many visible moles tend to get checked more often, catching melanomas earlier when they’re thinner and easier to treat. The takeaway: awareness and consistent monitoring matter more than the number of moles on your skin.
Familial Atypical Mole Syndrome
Some people inherit a tendency to develop large numbers of atypical nevi along with a significantly higher melanoma risk. This is known as familial atypical multiple mole melanoma syndrome, or FAMMM. The diagnostic criteria include having one or more close relatives (parents, siblings, children, grandparents, aunts, or uncles) diagnosed with melanoma, many moles with atypical features across the body, and moles that show specific abnormalities under microscopic examination.
If you have dozens of unusual moles and melanoma runs in your family, your dermatologist may recommend genetic testing and a more intensive surveillance schedule. FAMMM is associated with mutations in genes that regulate cell growth, and confirming the diagnosis changes how aggressively your skin is monitored going forward.
How Monitoring Works
For people with multiple atypical nevi or other risk factors, dermatologists use a combination of total body photography and digital dermoscopy. Total body photography means standardized photos of your entire skin surface are taken as a baseline. At future visits, your dermatologist compares new photos against the baseline to spot moles that have changed, appeared, or disappeared.
This is often paired with dermoscopy, where a handheld magnifying device captures detailed images of individual suspicious moles. Depending on your risk level, these images may be reviewed every three to four months or annually. Any changes seen at a short-term follow-up (typically three months) are considered grounds for biopsy or removal. In studies of high-risk patients, 10 to 20 percent of melanomas were caught specifically because of changes detected through baseline photography.
The International Dermoscopy Society recommends total body photography for patients with more than 60 moles, those with a personal history of melanoma and more than 40 moles, those with certain high-risk genetic variants, and organ transplant recipients with more than 40 moles. Even if you don’t meet those thresholds, annual skin exams remain important if you have any atypical nevi.
What You Can Do at Home
Monthly self-exams are a practical complement to professional monitoring. Use a full-length mirror and a hand mirror to check areas you can’t easily see, including your back, scalp, and the soles of your feet. You’re looking for new moles, existing moles that have changed in size, shape, or color, and any spot that looks distinctly different from all your other moles (the “ugly duckling” sign). Smartphone photos of individual moles, taken in consistent lighting, can help you track subtle changes between dermatology visits.
Sun protection also plays a role. Ultraviolet radiation drives DNA damage in skin cells, and while atypical nevi aren’t caused solely by sun exposure, UV light can accelerate changes in moles that are already genetically predisposed to abnormality. Broad-spectrum sunscreen, protective clothing, and avoiding peak UV hours reduce cumulative damage over time.